OBJECTIVE-The contribution of innate immunity responsible for aggressive b-cell destruction in human fulminant type 1 diabetes is unclear.
RESULTS-RIG-I was strongly expressed in b-cells in all three pancreata infected with enterovirus. Melanoma differentiationassociated gene-5 was hyperexpressed in islet cells, including b-and a-cells. TLR3 and TLR4 were expressed in mononuclear cells that infiltrated islets. Interferon (IFN)-a and IFN-b were strongly expressed in islet cells. Major histocompatibility complex (MHC)-class I, IFN-g, interleukin-18, and CXC motif ligand 10 were expressed and colocalized in affected islets. CD11c+ MHC-class II+ dendritic cells and macrophage subsets infiltrated most islets and showed remarkable features of phagocytosis of islet cell debris. CD4+ forkhead box P3+ regulatory T cells were not observed in and around the affected islets. Mononuclear cells expressed the Fas ligand and infiltrated most Fas-expressing islets. Retinoic acid-receptor responder 3 and activated caspases 8, 9, and 3 were preferentially expressed in b-cells. Serum levels of IFN-g were markedly increased in patients with fulminant type 1 diabetes.
CONCLUSIONS-These findings demonstrate the presence of specific innate immune responses to enterovirus infection connected with enhanced adoptive immune pathways responsible for aggressive b-cell toxicity in fulminant type 1 diabetes. Diabetes 60:884-889, 2011 F ulminant type 1 diabetes is a unique subtype of type 1 diabetes and is characterized by an abrupt onset of severe hyperglycemia/ketoacidosis and severe b-cell damage that is preceded by flulike symptoms (1) (2) (3) . Recently, we have reported unique enterovirus-induced mechanisms for b-cell destruction involving CXC chemokine ligand 10 (CXCL10) and chemokine receptor CXCR3 in fulminant type 1 diabetes (4) .
In this study, we examined the in situ status of innate and adaptive immunity of enterovirus-induced fulminant type 1 diabetes. This includes expression of Toll-like receptors (TLRs) TLR3 and TLR4 and cytoplasmic retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) RIG-I and melanoma differentiation-associated gene-5 (MDA5). TLRs and RLRs are major receptor systems for detecting RNA viruses like enterovirus (5) . As interferon (IFN)-a and -b potentially inhibit viral replication and enhance cytotoxic b-cell immunity (6), their expression, cytokine/chemokine expression, and activity of dendritic cells (DCs)/macrophages, CD4+ forkhead box P3 (Foxp3)+ regulatory T cells (Tregs) in affected islet cells were examined.
RESEARCH DESIGN AND METHODS
Patients. Clinical profiles of three autopsied patients with fulminant type 1 diabetes have been reported (4) . Briefly, case 1 was a 14-year-old boy who died from diabetic ketoacidosis, following flu-like symptoms 5 days earlier. Case 2 was a 25-year-old man who died from diabetic ketoacidosis, following sudden symptoms of nausea and epigastralgia 2 days earlier. Case 3 was a 29-year-old man who died from diabetic ketoacidosis, following slight fever, nausea, and vomiting 2 days earlier.
Control subjects. Pancreatic tissues from 10 nondiabetic men (mean age 6 SD, 62 6 10 years) with gastric carcinoma who had undergone partial pancreatectomy and from five autopsied nondiabetic men (65 6 11 years) were used as nondiabetic control subjects for immunohistochemical analysis. Pancreatic tissues from four autopsied type 1 diabetic patients (44 6 9 years) who had histopathological insulitis and glutamic acid decarboxylase autoantibodies (titer: 3.0 6 1.5 U/mL, cutoff ,1.5) were examined as type 1 diabetic control subjects. Immunostaining. Methods for immunohistochemical analyses have been reported previously (4) . Primary antibodies used in this study are listed in Supplementary Table 1 . The definition of insulitis and frequencies of insulitis and mononuclear cell (MNC) phenotypes in islets of cases 1-3 have been documented previously (4) . The number of pancreatic acinar cells surrounded by CD8+ T cells was counted in the randomly selected 60 photos of pancreatic section in each case. A confocal laser-scanning microscope, Fluoview FV1000 (Olympus, Tokyo, Japan), was also used. Measurement of serum IFN-g. We obtained sera from 18 
RESULTS

MDA5
, RIG-I, and enterovirus-capsid protein expression. MDA5 was strongly expressed in b-cells, a-cells, and other types of islet cells of fulminant type 1 diabetic pancreata ( Fig. 1A-D) . In nondiabetic control and type 1 diabetic control subjects, weak MDA5 expression was observed in a few a-cells ( Supplementary Fig. 1 ). Significant expression of RIG-I was observed preferentially in b-cells in all three patients with fulminant type 1 diabetes ( Fig. 1E-H ), yet it was not expressed in nondiabetic and type 1 diabetic control subjects ( Supplementary Fig. 1 ). Enterovirus-capsid protein (VP1) was detected in b-and non-b-cells of fulminant type 1 diabetic pancreata confirming our previous report ( Supplementary Fig. 2 ) (4) but not type 1 diabetic control and nondiabetic control subjects. TLR3 and TLR4 expression. Both TLR3 and TLR4 were expressed in MNCs that had infiltrated islets of fulminant type 1 diabetic pancreata but not nondiabetic and type 1 diabetic control subjects (Table 1) . IFN-a, IFN-b, interferon regulatory factor-7, and major histocompatibility complex class I expression. In all three pancreata of the patients with fulminant type 1 diabetes, IFN-a and -b 1 were strongly expressed ( Fig. 2A-F ). Some MNCs that had infiltrated around or in islets and pancreatic acinar and ductal cells also expressed theses cytokines in fulminant type 1 diabetes ( Fig. 2A and B) but not in either control subject. The numbers of pancreatic acinar cells surrounded by CD8+ T cells were 11/mm 2 , 24/mm 2 , and 22/mm 2 , respectively, in the pancreatic sections of cases 1, 2, and 3. Most IFN-a-expressing cells were b-cells, a-cells, and islet non-b-and non-a-cells (Fig. 2C-F) . Interferon regulatory factor (IRF)-7 (7) was strongly expressed in b-and a-cells (Fig. 2G-I ) and mostly stained around and in the nucleus of the islet cells (Fig. 2G) . Major histocompatibility complex class I (MHC-I) was hyperexpressed in all islet cell subsets of fulminant type 1 diabetic pancreata (Fig. 2J) . Nondiabetic control and type 1 diabetic control subjects did not show expression of IFN-a, IFN-b 1 , or IRF-7 and hyperexpression of MHC-I in their islets. CD11c+ cells in islets. Remarkable CD11c+ cells migration to the islets was observed in most islets of fulminant type 1 diabetic pancreata (Table 1) . Intraislet CD11c+ cells expressed MHC class-II molecules (Fig. 2K-N) . Confocal microscopy showed that some CD11c+ cells contained b-cell debris positive for insulin (Fig. 2O) . Such findings were not observed in islets of nondiabetic or type 1 diabetic control subjects. Most CD11c+ cells were also positive for CD1a and some for CD68 (Fig. 2P) , likely representing DCs and macrophage subsets. CD56+ or CD57+ NK cells and Tregs (CD4+ Foxp3+ cells) were not detected in or around islets of fulminant type 1 diabetic pancreata and either control. Tregs, CD4+ Foxp3+ cells, were not detected in or around the islets or in exocrine regions of the pancreas in fulminant type 1 diabetic, nondiabetic control, or type 1 diabetic control subjects (Table 1) . IL-18, IFN-g, and CXCL10 expression. IL-18 was expressed in islet cells in all three fulminant type 1 diabetes ( Fig. 3A and E) . Most residual b-cells expressed both IFN-g and IL-18 ( Fig. 3G and H) . IL-18, IFN-g, and CXCL10 colocalized in most b-and islet non-b-cells (Fig.  3A-H IFN-g, and CXCL10 . Serum IFN-g levels in patients with fulminant type 1 diabetes. Serum levels of IFN-g in patients with fulminant type 1 diabetes were approximately three times higher than those in nondiabetic and type 1 diabetic control subjects (Fig. 3I) . Fas expression in islet cells and infiltration of islet Fas-ligand-bearing MNCs. Elevated expression of Fas in islet cells coincided with marked MNC infiltration in fulminant type 1 diabetic pancreata (Fig. 3J) . The subsets of islet cells with Fas expression were mostly b-cells. Fasligand (FasL)-bearing MNCs infiltrated most islets of fulminant type 1 diabetic pancreata (Fig. 3K-M) (Table 1) . In islet cells of nondiabetic control and type 1 diabetic control subjects, Fas was not expressed ( Supplementary  Fig. 3 ). FasL-bearing MNC infiltration of islets was observed in type 1 diabetic but not nondiabetic control subjects (Table 1) (Supplementary Fig. 3) . Expression of retinoic acid-receptor responder 3 and activated caspases 8, 9, and 3 in islet b-cells. Retinoic acid-receptor responder 3 (RARRES3) (8,9) was expressed in b-cells of fulminant type 1 diabetic pancreata ( Supplementary Fig. 4 ). Cleaved caspase 8, a marker of the Fas-mediated extrinsic apoptotic pathway, cleaved caspase 9, a marker of the activated non-Fas-mediated apoptotic pathway, and activated caspases 3, a marker of the end stage of b-cell apoptosis, were expressed specifically in islet b-cells ( Supplementary Fig. 4 ). In islets of autopsied nondiabetic control subjects, RARRES3, cleaved caspases 8, -9, and -3 were not expressed ( Supplementary Fig. 5 ). In type 1 diabetic control subjects, RARRES3, cleaved caspases 8, -9, and -3 were expressed weakly in some islet b-cells ( Supplementary Fig. 5 ).
DISCUSSION
Both RIG-I and MDA5 were strongly expressed in b-cells of fulminant type 1 diabetic pancreata. MDA5 was also hyperexpressed in a-cells and non2b-/non-a-cells in affected islets. Hyperexpression of RIG-I and MDA5 with expression of IFN-a and -b 1 in b-cells suggests a crucial role of RIG-I and MDA5 for sensing and responding to enterovirus infection in the pancreas of patients with fulminant type 1 diabetes. Mutations of MDA5 genes have been implicated in reducing the risk of type 1 diabetes (10) . Reports also noted RIG-I mRNA expression in human islets infected with Coxsackievirus B3 and B5 (11, 12) . We showed that IRF-7, a master transcription factor of IFN-a and -b (7), translocated to the nucleus and that IFN-a and -b, essential factors that protect b-cells against viral infection (6), were strongly expressed in both b-and a-cells. These results indicate that all islet cells are in an activated state of innate immunity in response to enterovirus in patients with fulminant type 1 diabetes.
Increased TLR3+ MNCs that infiltrate affected islets should participate in sensing viral RNA and subsequently destroy b-cells with RIG-I-and MDA5-initiated proinflammatory signal axes in the innate immune response against Coxsackievirus B3 (13) . Intra-and peri-islet DCs and macrophage subsets drastically increased in number and showed active phagocytosis of enterovirus-infected b-cells, whereas MHC-I was hyperexpressed in all islet subsets. Some DCs and macrophage subsets also expressed MHC-II molecules. Activated innate immune responses including virus sensing by RIG-I and MDA5 with subsequent IFN-a and -b production and DC and macrophage activation will not only protect for enteroviral infection by upregulating RIG-I and MDA5 (12, 14) but will also enhance the adaptive immunity cascades for islet cell destruction (6,15,16) . Indeed, patients with fulminant type 1 diabetes showed elevated serum levels of IFN-g. TABLE 1 Frequency of islets with MNCs that express TLR3, TLR4, CD11c, CD4+Foxp3, and FasL in three fulminant type 1 diabetic cases, and nondiabetic and type 1 diabetic control subjects CD4+ Foxp3+ cells, which represent a pivotal subset of Tregs, were not observed in or around the islets of fulminant type 1 diabetic pancreata, suggesting that the extremely polarized local condition to predominance for Th1 in response to enteroviral infection suppresses Treg differentiation from naive T CD4+ precursors (17) . In turn, the Treg-depleted islet condition enhances Th1 cytokine (i.e., IFN-g) generation.
Notably, IL-18, an IFN-g-inducing factor, was extensively expressed in islet cells of infected fulminant type 1 diabetic pancreata. In response to viral infection, IL-18 is promptly secreted from virus-activated macrophages, DCs, and T cells (18) , stimulating production of IFN-g synergistically with IFN-a and -b through a unique pathway that sometimes occurs independently of IL-12 or NK cells (19) . Conversely, IL-18 can be induced by IFN-g alone or in combination with other cytokines in islet b-cells (20) . Thus, for fulminant type 1 diabetes, enterovirus itself or enterovirus-activated T cells and macrophages most likely infiltrate islets to induce IL-18 production in these cells. In addition, IFN-a and -b, produced in islet cells and isletinfiltrating MNCs, can enhance IL-18-mediated signaling (21) . Subsequently, islet-secreted IL-18 may induce IFN-g production via receptors on the islet cells or islet stromal cells in an autocrine/paracrine manner. Once this positive autocrine/paracrine circuit for production of IL-18, IFN-g, and CXCL10 is established in islet cells, destructive mechanisms involving CXCR3+ T cells and macrophages might persist until complete destruction of the b-cells (4).
We found that Fas was highly expressed in affected islet b-cells and islet-infiltrating FasL+ cells. Taken together with the finding that MHC-I and IFN-a, -b, and -g were strongly expressed in affected islet cells, effecter mechanisms for b-cell apoptosis in fulminant type 1 diabetes are likely mediated in part by MHC-I and by the Fas-FasL pathway (22) . Inflammation-induced Fas-FasL expression in b-cells was reported to lead to rapid and massive b-cell destruction (23) . Other apoptotic mechanisms through the IFN-g-dependent JAK/STAT pathway (24) and innate immune pathway (25) will also exert b-cell destruction.
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